Drug intelligence / Profile preview

Vicks VapoInhaler

Development stage
Unknown
Lead developer
Procter & Gamble
Modality
Small Molecules
Administration
Inhalation, Intranasal
01

Overview

Vicks VapoInhaler is a portable, over-the-counter nasal inhaler designed to provide soothing vapors for temporary relief of nasal congestion. The product is available in both medicated and non-medicated versions. The medicated version contains levmetamfetamine (levomethamphetamine), a sympathomimetic vasoconstrictor that acts as a topical nasal decongestant by constricting blood vessels in the nasal passages, thereby reducing swelling and congestion[1][3][4]. The non-medicated version provides only aromatic relief using menthol, camphor, methyl salicylate, and Siberian fir oil[2][10]. Developed for on-the-go use, it is intended for adults and children 12 years or older. Procter & Gamble developed the original branded product.

Brand names
Vicks VapoInhaler
Other names
Vapor InhalerNon-Medicated Vicks VapoInhalerLeader Vapor Inhaler
02

Targets

TAAR (Trace amine-associated receptors)

Beyond the preview

Go deeper on Vicks VapoInhaler.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vicks VapoInhaler.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call